Cardiac Resuscitation Devices Market is anticipated to grow at a CAGR of 6-7% between 2024 and 2029.

Increased demand for medical and healthcare services, an increase in the frequency of sudden cardiac arrest, technological advancements, improved awareness and training, an aging population in the population, favorable government initiatives, and an increasing use of these devices in non-traditional settings are some of the factors driving the growth of the cardiopulmonary resuscitation (CPR) devices market. To learn more about the research report, download a sample report. Cardiac resuscitation, also known as cardiopulmonary resuscitation (CPR), is an emergency procedure performed on individuals experiencing cardiac arrest, a condition where the heart suddenly stops beating effectively. CPR involves a combination of chest compressions and rescue breaths to maintain blood flow and oxygenation to […]

Continue Reading

Global Vaccine Contract Development and Manufacturing Organization (CDMO) market is estimated to develop at a CAGR of 8-10%, reaching around $5 billion by 2025

Driven by increased demand from biotech vaccine producers and more selective outsourcing by pharmaceutical firms in the vaccine CDMO industry. Vaccine manufacturing is a highly complex process compared to small molecules. The global vaccine end-market is dominated by big 4 Pharma (GSK, Pfizer, Merck, Sanofi) controlling 90% of value, while players like SII, Bharat Biotech […]

Continue Reading

Global gastrointestinal devices MedTech market growth would be driven by an increasing adoption of single use endoscopes, robotics, and growing focus on AI in surgeries.

Ageing population, rising number of GI procedures, growing cases of colorectal cancer and screening mandates in many healthcare systems is driving the Gastrointestinal Devices MedTech market growth. Rising usage of robotics and focus on AI are offering further impetus for the market growth. Medi-Tech Insights’ latest research insight on Gastrointestinal Devices MedTech market analyses the […]

Continue Reading

Global Allergy Diagnostics Market valued at ~$4.9 billion (2021) is set to witness a healthy growth rate of 11% in the next 5 years.

Expanding cases of allergic diseases (asthma, allergic rhinitis, atopic dermatitis, and food allergy), rising environmental pollution levels, high volume consumption of processed foods and beverages, the introduction of mHealth in allergy diagnosis and care, and rising awareness about allergic diseases are among the key factors driving the Global Allergy Diagnostics Market. Allergies are body’s reaction to […]

Continue Reading

The Cardiology Information System (CIS) Market is projected to grow at a healthy CAGR of 8-10% over the next few years.

The increased prevalence of cardiovascular disorders such as CAD and strokes is the key driver of market development. Furthermore, there is a growing demand for effective data management tools, a shift toward cloud-based solutions, a need for real-time data analysis, a surge in demand for electronic health records, and a growing preference for individualized care. […]

Continue Reading

Global real-world evidence solutions is poised to grow at a significant rate in the coming future

The worldwide real-world evidence solutions market is expanding due to greater regulatory support for RWE adoption, increased financing from pharmaceutical firms, and more insights provided when compared to randomized clinical trials (RCTs). Real-world evidence (RWE) is the clinical evidence regarding usage and potential benefits/risks of a medical product based on analysis of the real-world data. […]

Continue Reading

The Cardiac Safety Services Market is projected to grow at a steady rate of 11-12% during the forecast period.

The cardiac safety services market is being driven by various factors, including the pharmaceutical industry’s expansion and increasing drug development activities, the demand for precision medicine, the escalating prevalence of cardiovascular diseases mandating comprehensive safety assessments, advancements in real-time monitoring technologies, and the increasing utilization of biomarkers for early risk detection. Cardiac safety services encompass […]

Continue Reading

Global biosimilars market growth is driven by the increasing number of biosimilar approvals and the rising number of biologics coming off patent.

A biosimilar is a biological product that is similar to a reference biologic with no clinically meaningful differences in terms of potency, purity, and safety. The growth in the biosimilars market is driven by growing number of off-patent molecules, rising focus of key players on biosimilar development, and the cost benefits offered by biosimilars compared […]

Continue Reading

Global Sepsis Diagnostics Market valued at ~$510 million (2021) is poised to observe a high CAGR of 9% in the next 5 years.

Development of rapid diagnostic tests/point-of-care techniques, growing cases of sepsis & hospital-acquired infections, and favorable initiatives & funding for sepsis-related research are some of the key factors driving the Global Sepsis Diagnostics Market. However, limited awareness about sepsis is likely to hamper the growth of the Sepsis Diagnostic market. The market is marked by presence […]

Continue Reading

Global virtual clinical trials market is expected to be worth over $8 billion by 2020, with a compound annual growth rate of more than 10%.

The market growth is driven by growing adoption of virtual trials following outbreak of COVID-19 pandemic. A virtual clinical trial (also known as remote/decentralized clinical trials) refers to digitally empowered clinical trial processes. This is a relatively new model of clinical trials and is currently underutilized but highly potential means of conducting clinical research. Find […]

Continue Reading